We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-17.53%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$1.59B
AUM Growth
-$2.52B
Cap. Flow
-$1.91B
Cap. Flow %
-120.24%
Top 10 Hldgs %
15.88%
Holding
1,717
New
455
Increased
296
Reduced
338
Closed
624

Sector Composition

Rank Sector Weight
1 Technology 18.61%
2 Financials 14.75%
3 Consumer Discretionary 13.2%
4 Healthcare 12.64%
5 Communication Services 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRRM icon
951
Verra Mobility
VRRM
$744M
$157K 0.01%
22,000
-261,965
-92% -$3.49M
CYTK icon
952
Cytokinetics
CYTK
$10.4B
$156K 0.01%
+13,263
New +$169K
NFH
953
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$156K 0.01%
+18,966
New +$172K
BKE icon
954
Buckle
BKE
$2.37B
$155K 0.01%
11,300
-296
-3% -$6.66K
CWK icon
955
Cushman & Wakefield Ltd
CWK
$3.25B
$155K 0.01%
13,200
-4,360
-25% -$75.2K
EQNR icon
956
Equinor
EQNR
$92.4B
$155K 0.01%
+12,700
New +$205K
LOCO icon
957
El Pollo Loco
LOCO
$462M
$155K 0.01%
+18,400
New +$234K
OVV icon
958
Ovintiv
OVV
$16.4B
$155K 0.01%
+57,542
New +$756K
DXC icon
959
DXC Technology
DXC
$1.73B
$154K 0.01%
+11,813
New +$312K
CLB icon
960
Core Laboratories
CLB
$521M
$151K 0.01%
14,600
-6,262
-30% -$175K
PBYI icon
961
Puma Biotechnology
PBYI
$454M
$148K 0.01%
17,582
-61,106
-78% -$594K
XAIR icon
962
Beyond Air
XAIR
$3.86M
$147K 0.01%
46
-546
-92% -$1.42M
XENE icon
963
Xenon Pharmaceuticals
XENE
$6.12B
$147K 0.01%
13,000
-56,400
-81% -$803K
TRVG
964
trivago
TRVG
$397M
$146K 0.01%
20,000
-19,080
-49% -$216K
KGC icon
965
Kinross Gold
KGC
$32.8B
$144K 0.01%
+36,200
New +$175K
PGRE
966
DELISTED
Paramount Group
PGRE
$143K 0.01%
16,200
-8,335
-34% -$103K
LILAK icon
967
Liberty Latin America Class C
LILAK
$1.64B
$140K 0.01%
+15,888
New +$214K
MOV icon
968
Movado Group
MOV
$841M
$138K 0.01%
+11,700
New +$185K
FNKO icon
969
Funko
FNKO
$328M
$136K 0.01%
34,100
-116,366
-77% -$1.19M
BDSI
970
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$136K 0.01%
+35,992
New +$177K
FLWS icon
971
1-800-Flowers.com
FLWS
$258M
$134K 0.01%
+10,100
New +$156K
OLOX
972
Olenox Industries
OLOX
$4.5M
$134K 0.01%
+2
New +$34.8K
SEI
973
Solaris Energy Infrastructure
SEI
$3.82B
$134K 0.01%
25,600
+14,200
+125% +$149K
ANGI icon
974
Angi Inc
ANGI
$196M
$131K 0.01%
+2,490
New +$185K
NPTN
975
DELISTED
NEOPHOTONICS CORP
NPTN
$131K 0.01%
18,100
+900
+5% +$6.67K

Similar funds

Schonfeld Strategic Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Schonfeld Strategic Advisors held 1,717 positions worth $1.59B, down 61% from $4.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Schonfeld Strategic Advisors withdrew a net $1.91B in Q1 2020, closing 624 positions and reducing 338 holdings. Its most notable exit was Vistra, an estimated $89.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Schonfeld Strategic Advisors opened a new position in Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt worth $30M.

  • Schonfeld Strategic Advisors's largest Q1 2020 buy was Churchill Capital Corp III Units, each consisting of one share of Class A Common Stock and one-fourt: 3,000,000 shares worth $30M.
  • Schonfeld Strategic Advisors added most to Allergan plc in Q1 2020, an estimated $26.9M increase.
  • Schonfeld Strategic Advisors's biggest Q1 2020 reduction was Cheniere Energy, cutting an estimated $63.1M.
  • Schonfeld Strategic Advisors fully exited Vistra in Q1 2020, selling an estimated $89.7M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 16% of its $1.59B portfolio in Q1 2020.
  • Schonfeld Strategic Advisors opened 455 new positions and closed 624 in Q1 2020.
  • Schonfeld Strategic Advisors's portfolio value fell 61% quarter-over-quarter to $1.59B.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.